These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

706 related items for PubMed ID: 26497471

  • 21. Posttransplantation lymphoproliferative disorder in lung transplant recipients: a 15-year single institution experience.
    Muchtar E, Kramer MR, Vidal L, Ram R, Gurion R, Rosenblat Y, Bakal I, Shpilberg O.
    Transplantation; 2013 Oct 15; 96(7):657-63. PubMed ID: 23823652
    [Abstract] [Full Text] [Related]

  • 22. Course of renal allograft function after diagnosis and treatment of post-transplant lymphoproliferative disorders in pediatric kidney transplant recipients.
    Zierhut H, Kanzelmeyer N, Buescher A, Höcker B, Mauz-Körholz C, Tönshoff B, Metzler M, Pohl M, Pape L, Maecker-Kolhoff B.
    Pediatr Transplant; 2021 Sep 15; 25(6):e14042. PubMed ID: 34021949
    [Abstract] [Full Text] [Related]

  • 23. Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience.
    Mendizabal M, Marciano S, dos Santos Schraiber L, Zapata R, Quiros R, Zanotelli ML, Rivas MM, Kusminsky G, Humeres R, Alves de Mattos A, Gadano A, Silva MO.
    Clin Transplant; 2013 Sep 15; 27(4):E469-77. PubMed ID: 23758407
    [Abstract] [Full Text] [Related]

  • 24. Acute renal allograft rejection in patients with Epstein-Barr virus associated post-transplant lymphoproliferative disorder.
    Purighalla R, Shapiro R, Jordan ML, Scantlebury VP, Gritsch HA, Vivas C, Randhawa PS.
    Clin Transplant; 1997 Dec 15; 11(6):574-6. PubMed ID: 9408687
    [Abstract] [Full Text] [Related]

  • 25. Graft rejection in pediatric liver transplant patients with Epstein-Barr viremia and post-transplant lymphoproliferative disease.
    Weiner C, Weintraub L, Wistinghausen B, Tomaino J, Arnon R, Kerkar N, Miloh T.
    Pediatr Transplant; 2012 Aug 15; 16(5):458-64. PubMed ID: 22554096
    [Abstract] [Full Text] [Related]

  • 26. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.
    J Heart Lung Transplant; 2008 Jan 15; 27(1):100-5. PubMed ID: 18187094
    [Abstract] [Full Text] [Related]

  • 27. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
    Shapiro R, Nalesnik M, McCauley J, Fedorek S, Jordan ML, Scantlebury VP, Jain A, Vivas C, Ellis D, Lombardozzi-Lane S, Randhawa P, Johnston J, Hakala TR, Simmons RL, Fung JJ, Starzl TE.
    Transplantation; 1999 Dec 27; 68(12):1851-4. PubMed ID: 10628763
    [Abstract] [Full Text] [Related]

  • 28. Posttransplant Lymphoproliferative Disorders in Irish Renal Transplant Recipients: Insights From a National Observational Study.
    OʼRegan JA, Prendeville S, McCaughan JA, Traynor C, OʼBrien FJ, Ward FL, OʼDonovan D, Kennedy C, Berzan E, Kinsella S, Williams Y, OʼKelly P, Deady S, Comber H, Leader M, Conlon PJ.
    Transplantation; 2017 Mar 27; 101(3):657-663. PubMed ID: 27214265
    [Abstract] [Full Text] [Related]

  • 29. Retransplantation after post transplant lymphoproliferative disorder: overcoming the obstacles!
    Prasad P, Khullar D, Gupta N, Grover R, Chhabra G, Gandhi KR, Gupta S, Bagai S.
    CEN Case Rep; 2020 Aug 27; 9(3):200-203. PubMed ID: 32016786
    [Abstract] [Full Text] [Related]

  • 30. Postransplant lymphoproliferative disorder localized near the allograft in renal transplantation.
    Kew CE, Lopez-Ben R, Smith JK, Robbin ML, Cook WJ, Gaston RS, Deierhoi MH, Julian BA.
    Transplantation; 2000 Mar 15; 69(5):809-14. PubMed ID: 10755531
    [Abstract] [Full Text] [Related]

  • 31. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression.
    Newell KA, Alonso EM, Whitington PF, Bruce DS, Millis JM, Piper JB, Woodle ES, Kelly SM, Koeppen H, Hart J, Rubin CM, Thistlethwaite JR.
    Transplantation; 1996 Aug 15; 62(3):370-5. PubMed ID: 8779685
    [Abstract] [Full Text] [Related]

  • 32. Rational management of posttransplant lymphoproliferative disorder in pediatric recipients.
    Praghakaran K, Wise B, Chen A, Schwarz K, Colombani P.
    J Pediatr Surg; 1999 Jan 15; 34(1):112-5; discussion 115-6. PubMed ID: 10022154
    [Abstract] [Full Text] [Related]

  • 33. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.
    Miyagi S, Sekiguchi S, Kawagishi N, Akamatsu Y, Satoh K, Takeda I, Fukushima D, Kobayashi Y, Tokodai K, Fujimori K, Satomi S.
    Transplant Proc; 2011 Nov 15; 43(9):3299-301. PubMed ID: 22099782
    [Abstract] [Full Text] [Related]

  • 34. Lung retransplantation after posttransplantation lymphoproliferative disorder (PTLD): a single-center experience and review of literature of PTLD in lung transplant recipients.
    Raj R, Frost AE.
    J Heart Lung Transplant; 2005 Jun 15; 24(6):671-9. PubMed ID: 15949726
    [Abstract] [Full Text] [Related]

  • 35. Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy.
    Cacciarelli TV, Green M, Jaffe R, Mazariegos GV, Jain A, Fung JJ, Reyes J.
    Transplantation; 1998 Oct 27; 66(8):1047-52. PubMed ID: 9808490
    [Abstract] [Full Text] [Related]

  • 36. Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.
    Gross TG, Bucuvalas JC, Park JR, Greiner TC, Hinrich SH, Kaufman SS, Langnas AN, McDonald RA, Ryckman FC, Shaw BW, Sudan DL, Lynch JC.
    J Clin Oncol; 2005 Sep 20; 23(27):6481-8. PubMed ID: 16170157
    [Abstract] [Full Text] [Related]

  • 37. Posttransplant lymphoproliferative disease: treatment and outcome in renal transplant recipients.
    Soler MJ, Puig JM, Mir M, Parrilla J, Pedro C, Salar A, Serrano S, Lloveras J.
    Transplant Proc; 2003 Aug 20; 35(5):1709-13. PubMed ID: 12962767
    [Abstract] [Full Text] [Related]

  • 38. Post-transplant lymphoproliferative disorders in lung transplant recipients: 20-yr experience at the University of Minnesota.
    Wudhikarn K, Holman CJ, Linan M, Blaes AH, Dunitz JM, Hertz ME, Peterson BA.
    Clin Transplant; 2011 Aug 20; 25(5):705-13. PubMed ID: 21077949
    [Abstract] [Full Text] [Related]

  • 39. Thoracic presentations of posttransplant lymphoproliferative disorders.
    Halkos ME, Miller JI, Mann KP, Miller DL, Gal AA.
    Chest; 2004 Dec 20; 126(6):2013-20. PubMed ID: 15596707
    [Abstract] [Full Text] [Related]

  • 40. An approach to finding indications and contraindications for nephrectomy in post-transplant renal graft lymphomas: PTLD.Int survey.
    Gholipour-Shoiili A, Gholipour-Shoiili H, Taheri S.
    Hematol Oncol Stem Cell Ther; 2011 Dec 20; 4(4):167-72. PubMed ID: 22198192
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.